Gastrointestinal Cancer News

A large epidemiological study published in the International Journal of Cancer reported that nitrate in drinking water, even at low levels, correlated with an increased risk for colorectal cancer.

A 4-month course of induction therapy with modified FOLFOXIRI and cetuximab produced significant activity and appeared feasible for patients with RAS and BRAF wild-type metastatic colorectal cancer, according to researchers in Italy.

Larotrectinib showed activity in adults and children with TRK fusion-positive cancers, according to findings published in The New England Journal of Medicine.

Older patients with inflammatory bowel disease who have recently taken immunomodulators were more likely to have or develop cancer, according to research presented at the Congress of the European Crohn’s and Colitis Organisation.

Patients with pancreatic cancer who had tumors with a combination of the highest neoantigen number and the most abundant CD8-positive T-cell infiltrates survived significantly longer than those without those tumor characteristics, according to study results.

Patients who underwent esophagectomy after neoadjuvant therapy for esophageal cancer survived significantly longer than those who refused surgery, according to study results presented at the Annual Meeting of The Society of Thoracic Surgeons.

Individuals who ate more “ultra-processed” foods showed a higher risk for cancer in a large prospective study of adults in France.

Immune checkpoint inhibitor therapy should be discontinued when moderate to severe adverse events are present in treated patients, according to newly release guidelines from ASCO and the National Comprehensive Cancer Network.

Stand Up To Cancer, in collaboration with the Lustgarten Foundation for Pancreatic Cancer Research, is supporting a new translational research team that will explore how chimeric antigen receptor T-cell therapy can be applied to pancreatic cancer.

Two species of bacteria appear to work together to help the formation of colon cancer in patients with a hereditary form of the disease, according to a pair of new studies published in Cell Host & Microbe and Science.